These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cahill K; Ussher M Cochrane Database Syst Rev; 2007 Jul; (3):CD005353. PubMed ID: 17636794 [TBL] [Abstract][Full Text] [Related]
5. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related]
7. Varying nicotine patch dose and type of smoking cessation counseling. Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial. Tonstad S; Aubin HJ J Psychopharmacol; 2012 Jul; 26(7):1003-9. PubMed ID: 22219220 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342 [TBL] [Abstract][Full Text] [Related]
10. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Gray KM; McClure EA; Baker NL; Hartwell KJ; Carpenter MJ; Saladin ME Addiction; 2015 Jun; 110(6):1027-34. PubMed ID: 25727442 [TBL] [Abstract][Full Text] [Related]
11. Interventions for preventing weight gain after smoking cessation. Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269 [TBL] [Abstract][Full Text] [Related]
12. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840 [TBL] [Abstract][Full Text] [Related]
13. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210 [TBL] [Abstract][Full Text] [Related]
14. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177 [TBL] [Abstract][Full Text] [Related]
15. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial. Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; van Schayck OC Addiction; 2014 Aug; 109(8):1252-9. PubMed ID: 24894625 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Davidson M; Epstein M; Burt R; Schaefer C; Whitworth G; McDonald A Arch Fam Med; 1998; 7(6):569-74. PubMed ID: 9821833 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR; JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547 [TBL] [Abstract][Full Text] [Related]
20. Combination Lorcaserin and Nicotine Patch for Smoking Cessation Without Weight Gain. Rose JE; Davis JM Nicotine Tob Res; 2020 Aug; 22(9):1627-1631. PubMed ID: 31589323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]